CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Alta Partners

Esperion Gets $33M To Continue Work On Cholesterol Buster

The Ann Arbor biotech firm Esperion Therapeutics Inc. announced that it has completed a $33 million preferred stock financing led by new investor Longitude Capital.

WWJ Newsradio 950–04/25/2013

Follow

Get every new post delivered to your Inbox.

Join 1,929 other followers